🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
PT Kimia Farma Tbk (IDX:KAEF)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
334.00
-14.00 (-4.02%)
Nov 20, 2026, 4:00 PM WIB

PT Kimia Farma Tbk Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,290,7419,223,3289,938,9589,871,8429,232,67612,857,627
Revenue Growth
2.29%-7.20%0.68%6.92%-28.19%28.50%
Cost of Revenue
6,302,0096,358,3237,247,3697,386,2455,717,5218,811,444
Gross Profit
2,988,7322,865,0052,691,5902,485,5983,515,1544,046,183
Selling, General & Admin
2,536,6912,567,2802,967,7403,681,0942,889,2032,860,390
Research & Development
29,42620,75131,620107,23446,36541,348
Other Operating Expenses
-53,969-82,655-55,43955,091-134,094-39,660
Operating Expenses
2,986,3792,984,1943,463,8364,197,8673,009,3213,090,225
Operating Income
2,353-119,189-772,246-1,712,269505,834955,958
Interest Expense
-579,179-586,324-640,832-597,149-525,608-606,813
Interest & Investment Income
30,78418,12510,28333,18312,16622,735
Currency Exchange Gain (Loss)
-1,831-2,323-1,966-2,044-1,1386,637
Other Non Operating Income (Expenses)
294,062217,456214,020---
EBT Excluding Unusual Items
-253,812-472,255-1,190,740-2,278,280-8,747378,517
Impairment of Goodwill
---53,877-26,889--
Gain (Loss) on Sale of Investments
6,172-15,153---
Gain (Loss) on Sale of Assets
55-7,6432,022-13,6032,112
Asset Writedown
-15,571-15,5717,40922,7035,95612,254
Other Unusual Items
49,73449,734----
Pretax Income
-213,472-438,087-1,229,699-2,280,444-16,394392,883
Income Tax Expense
8,6805,271-21,526-19,76094,175102,995
Earnings From Continuing Operations
-222,151-443,357-1,208,173-2,260,684-110,568289,889
Earnings From Discontinued Operations
-----15,456-
Net Income to Company
-222,151-443,357-1,208,173-2,260,684-126,024289,889
Minority Interest in Earnings
4,914108,398365,900296,528-64,44812,385
Net Income
-217,237-334,959-842,272-1,964,157-190,473302,274
Net Income to Common
-217,237-334,959-842,272-1,964,157-190,473302,274
Net Income Growth
-----1613.68%
Shares Outstanding (Basic)
5,5675,5675,5675,5625,5615,554
Shares Outstanding (Diluted)
5,5675,5675,5675,5625,5615,554
Shares Change
--0.08%0.01%0.13%-
EPS (Basic)
-39.03-60.17-151.31-353.14-34.2554.42
EPS (Diluted)
-39.03-60.17-151.31-353.14-37.0354.42
EPS Growth
-----1613.68%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
77,018102,078-48,103-1,113,887-499,985-874,686
Free Cash Flow Per Share
13.8418.34-8.64-200.27-89.91-157.49
Gross Margin
32.17%31.06%27.08%25.18%38.07%31.47%
Operating Margin
0.03%-1.29%-7.77%-17.34%5.48%7.43%
Profit Margin
-2.34%-3.63%-8.47%-19.90%-2.06%2.35%
Free Cash Flow Margin
0.83%1.11%-0.48%-11.28%-5.42%-6.80%
EBITDA
390,253219,579-407,971-1,182,970867,8211,300,090
EBITDA Margin
4.20%2.38%-4.11%-11.98%9.40%10.11%
D&A For EBITDA
387,900338,768364,276529,299361,987344,132
EBIT
2,353-119,189-772,246-1,712,269505,834955,958
EBIT Margin
0.03%-1.29%-7.77%-17.34%5.48%7.43%
Effective Tax Rate
-----26.21%
Advertising Expenses
-241,699403,294563,934403,189343,127